CHIGOZIE CHIDEBELU: Open Payments
NPI 1821827114 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,441 in 61 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $92 · 2025 $1,441
Food & beverage: $1,342Education: $100
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 20 | $345 |
| GENZYME CORPORATION | 12 | $342 |
| AstraZeneca Pharmaceuticals LP | 10 | $246 |
| JAZZ PHARMACEUTICALS INC. | 7 | $146 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Grifols USA, LLC | 4 | $92 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $74 |
| Verona Pharma, Inc. | 1 | $32 |
| Axsome Therapeutics, Inc. | 1 | $24 |
| Insmed, Inc. | 1 | $23 |
Products named: DUPIXENT, TRELEGY ELLIPTA, AIRSUPRA, XYWAV, NUCALA, Prolastin-C Liquid, GLASSIA, BREZTRI.
Industry payments across AL — which companies pay providers there.
